01 4Gowling WLG (Canada) LLP
01 22723148
02 22958666
01 4FRUQUINTINIB
01 4CAPSULE
01 21935-09-07
02 22029-05-08
Patent Expiration Date : 2029-05-08
Date Granted : 2015-01-20
Brand Name : FRUZAQLA
Patent Number : 2723148
Filing Date : 2009-05-08
Strength per Unit : 1 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-05-08
Date Granted : 2015-01-20
Patent Expiration Date : 1935-09-07
Date Granted : 2020-10-06
Brand Name : FRUZAQLA
Patent Number : 2958666
Filing Date : 2015-09-07
Strength per Unit : 1 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1935-09-07
Date Granted : 2020-10-06
Patent Expiration Date : 2029-05-08
Date Granted : 2015-01-20
Brand Name : FRUZAQLA
Patent Number : 2723148
Filing Date : 2009-05-08
Strength per Unit : 5 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-05-08
Date Granted : 2015-01-20
Patent Expiration Date : 1935-09-07
Date Granted : 2020-10-06
Brand Name : FRUZAQLA
Patent Number : 2958666
Filing Date : 2015-09-07
Strength per Unit : 5 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1935-09-07
Date Granted : 2020-10-06
